Biomarker-Based Point-of-Care Tests for the Evaluation of Mild Traumatic Brain Injury
Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.